Amedisys Inc
AMED Real Time Price USDRecent trades of AMED by members of U.S. Congress
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by AMED's directors and management
No recent Insider Trading for this ticker
Insider Trading DashboardGovernment lobbying spending instances
-
$340,000 Oct 18, 2024 Issue: Medicare/Medicaid
-
$310,000 Jul 22, 2024 Issue: Medicare/Medicaid
-
$840,000 Apr 22, 2024 Issue: Medicare/Medicaid
-
$80,000 Jan 22, 2024 Issue: Health Issues Medicare/Medicaid
-
$120,000 Jan 22, 2024 Issue: Health Issues
-
$460,000 Oct 19, 2023 Issue: Medicare/Medicaid
-
$490,000 Jul 19, 2023 Issue: Medicare/Medicaid
-
$430,000 Jan 18, 2023 Issue: Medicare/Medicaid
-
$410,000 Oct 19, 2022 Issue: Medicare/Medicaid
-
$280,000 Jul 15, 2022 Issue: Medicare/Medicaid
-
$290,000 Apr 20, 2022 Issue: Medicare/Medicaid
-
$230,000 Jan 14, 2022 Issue: Medicare/Medicaid
-
$230,000 Oct 15, 2021 Issue: Medicare/Medicaid
-
$230,000 Jul 15, 2021 Issue: Medicare/Medicaid
-
$260,000 Apr 16, 2021 Issue: Medicare/Medicaid
-
$240,000 Jan 19, 2021 Issue: Medicare/Medicaid
-
$230,000 Oct 20, 2020 Issue: Medicare/Medicaid
-
$310,000 Jul 20, 2020 Issue: Medicare/Medicaid
-
$280,000 Apr 10, 2020 Issue: Medicare/Medicaid
-
$240,000 Jan 13, 2020 Issue: Medicare/Medicaid
-
$260,000 Oct 17, 2019 Issue: Medicare/Medicaid
-
$250,000 Jul 18, 2019 Issue: Medicare/Medicaid
-
$270,000 Apr 15, 2019 Issue: Medicare/Medicaid
-
$290,000 Mar 25, 2019 Issue: Medicare/Medicaid
-
$190,000 Oct 16, 2018 Issue: Medicare/Medicaid
-
$150,000 Jul 13, 2018 Issue: Medicare/Medicaid
-
$190,000 Apr 19, 2018 Issue: Medicare/Medicaid
-
$210,000 Jan 16, 2018 Issue: Medicare/Medicaid
-
$120,000 Oct 20, 2017 Issue: Medicare/Medicaid
-
$60,000 Jul 18, 2017 Issue: Medicare/Medicaid
-
$210,000 Apr 19, 2017 Issue: Medicare/Medicaid
-
$80,000 Jan 23, 2017 Issue: Medicare/Medicaid
-
$130,000 Oct 20, 2016 Issue: Medicare/Medicaid
-
$240,000 Apr 21, 2014 Issue: Medicare/Medicaid
-
$297,719 Jan 21, 2014 Issue: Medicare/Medicaid
-
$291,044 Oct 21, 2013 Issue: Health Issues
-
$289,794 Jul 22, 2013 Issue: Health Issues
-
$277,700 Apr 22, 2013 Issue: Medicare/Medicaid
-
$50,000 Jan 17, 2013 Issue: Health Issues
-
$50,000 Oct 19, 2012 Issue: Health Issues
-
$50,000 Jul 18, 2012 Issue: Health Issues
-
$50,000 Apr 18, 2012 Issue: Health Issues
-
$50,000 Jan 19, 2012 Issue: Health Issues
-
$30,000 Oct 18, 2011 Issue: Health Issues
-
$10,000 Jul 20, 2010 Issue: Health Issues Science/Technology
-
$40,000 Apr 20, 2010 Issue: Science/Technology Health Issues
-
$40,000 Jan 20, 2010 Issue: Science/Technology Health Issues
-
$40,000 Oct 20, 2009 Issue: Health Issues Science/Technology
-
$10,000 Jul 20, 2009 Issue: Health Issues
-
$30,000 Jul 15, 2009 Issue: Health Issues Science/Technology
-
$30,000 Apr 20, 2009 Issue: Science/Technology Health Issues
-
$30,000 Apr 14, 2009 Issue: Health Issues
-
$30,000 Jan 16, 2009 Issue: Science/Technology Health Issues
-
$30,000 Jan 16, 2009 Issue: Health Issues
-
$30,000 Oct 20, 2008 Issue: Health Issues Science/Technology
-
$30,000 Oct 07, 2008 Issue: Health Issues
-
$30,000 Jul 18, 2008 Issue: Health Issues
-
$10,000 Jul 17, 2008 Issue: Health Issues Science/Technology
-
$30,000 Apr 18, 2008 Issue: Health Issues
-
$40,000 Jan 25, 2008 Issue: Health Issues
-
$30,000 Aug 03, 2007 Issue: Health Issues
-
$20,000 Mar 01, 2006 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
No new patents for this ticker
U.S. Patents DashboardFederal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of AMED in WallStreetBets Daily Discussion
Recent insights relating to AMED
Recent picks made for AMED stock on CNBC
ETFs with the largest estimated holdings in AMED
Shareholder
|
Shares Held
|
---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view AMED Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.